- Home
- BLTE vs TTD Comparison
BLTE vs TTD Comparison
Compare BLTE & TTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLTE | TTD |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.5B |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BLTE | TTD |
|---|---|---|
| Price | $147.72 | $12.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 36 |
| Target Price | ★ $228.89 | $13.53 |
| AVG Volume (30 Days) | 133.0K | ★ 13.6M |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.38 |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $2,896,284,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $59.57 |
| Revenue Growth | N/A | ★ 18.47 |
| 52 Week Low | $90.84 | $11.62 |
| 52 Week High | $200.00 | $54.05 |
Technical Indicators
Market Signals| Indicator | BLTE | TTD |
|---|---|---|
| Relative Strength Index (RSI) | 39.67 | 51.88 |
| Support Level | $145.21 | $12.97 |
| Resistance Level | $161.08 | $13.31 |
| Average True Range (ATR) | 5.89 | 0.50 |
| MACD | -0.37 | 0.18 |
| Stochastic Oscillator | 30.70 | 81.36 |
Price Performance
Historical ComparisonAbout BLTE Belite Bio Inc
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
About TTD The Trade Desk Inc.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. The firm's platform is referred to as a DSP in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising, sometimes referred to as a "take rate."